A potential epidemic clone of Salmonella enterica serotype Typhimurium DT104, and the possible emergence of S. enterica serotype Typhimurium DT104b, has been identified from the characterization of 67 S. enterica serotype Typhimurium strains from three sources, human gastroenteritis isolates, isolates from food samples, and veterinary isolates, by antimicrobial resistance profiling, phage typing, and pulsed-field gel electrophoresis. Resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline was found in 77.6% of these strains.
Worldwide, Salmonella has been recognized as an important food-borne pathogen. It can be isolated from raw meats, poultry and poultry products, and milk and milk products. Salmonella outbreaks have also been associated with poor cooking, reheating of foods, and improper handling of food by food preparers (12) .
Representing 30.4% of all Salmonella strains isolated from humans, Salmonella enterica serotype Typhimurium was the second most commonly isolated Salmonella serotype in the Republic of Ireland in 2001, exceeded only by S. enterica serotype Enteritidis (18) . Phage type DT104 is the phage type most frequently isolated from both cattle (8) and human patients (9) .
In 1984, the first strain of S. enterica serotype Typhimurium DT104 resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (resistance profile ACSSuT) was isolated in the United Kingdom (31) . However, it was in the early 1990s that a dramatic increase of this pentaresistance profile was observed not just in the United Kingdom (30) but worldwide (2, 4, 6, 10, 21) .
Despite the importance of Salmonella serotype Typhimurium in causing salmonellosis in Ireland, there have been a limited number of epidemiological studies of this organism (5, 6, 9, 15) . This study has applied a combination of phenotypic and genotypic typing methods, including pulsed-field gel electrophoresis (PFGE), which has been recognized as a powerful tool and the "gold standard" of molecular typing methods (19, 24) , in the analysis of S. enterica serotype Typhimurium DT104 and DT104b from human, food, and animal sources over a 2-year period in the midwest region of Ireland.
A total of 67 S. enterica serotype Typhimurium isolates were obtained during a 2-year study period from June 2000 to May 2002. These isolates included 28 strains from human gastroenteritis stool samples, 3 strains from food samples, and 36 veterinary strains, for a total of 67 strains. The strains were obtained from the Regional Hospital and Regional Veterinary Laboratory, Limerick, Ireland.
Antimicrobial disk susceptibility testing according to the method of the National Committee for Clinical Laboratory Standards (NCCLS) (16, 17) was carried out using 15 antimicrobial agents: ampicillin, coamoxiclavulanic acid, cefotaxime, chloramphenicol, ciprofloxacin, enrofloxacin, gentamicin, nalidixic acid, norfloxacin, ofloxacin, pefloxacin, streptomycin, sulfonamides, tetracycline, and trimethoprim-sulfamethoxazole. Escherichia coli ATCC 25922 was used as a control on each test occasion. An isolate was defined as being drug resistant if it was resistant to at least one of the tested antimicrobial agents and multidrug resistant if it was resistant to four or more of the antimicrobial agents tested (25) . Phage typing based on the Colindale method (1) was carried out in the Salmonella Reference Laboratory, Galway, Ireland.
PFGE was performed with the 54 S. enterica serotype Typhimurium DT104 and DT104b strains as well as two nonphage-typeable strains. The preparation of Salmonella plugs for PFGE was carried out according to the manufacturer's instructions (Bio-Rad). The restriction enzymes XbaI, SpeI, and BlnI were used to develop the PFGE profiles. Chromosomal DNA restriction patterns produced by PFGE were interpreted by the criteria of Tenover et al. (24) for bacterial strain typing. Statistical analysis of PFGE profiles was carried out by using the Dice coefficient (7).
Antimicrobial susceptibility test results showed a total of 16 resistance profiles for S. enterica serotype Typhimurium as summarized in Table 1 . All but one strain of S. enterica serotype Typhimurium (66 of 67 strains [98.5%]) collected in this study expressed drug resistance, and 88% (59 of 67 strains) expressed multidrug resistance. The pentaresistance profile ACSSuT was observed in 77.6% (52 of 67) of the S. enterica serotype Typhimurium strains. In addition, 19.4% (13 of 67) of the isolates expressed trimethoprim-sulfamethoxazole resistance, 3% (2 of 67) expressed nalidixic acid resistance, and 7.5% (5 of 67) expressed intermediate resistance to coamoxiclavulanic acid (Table 1) .
Phage type DT104 accounted for 63% (42 of 67) of the isolates and was observed in all three sources, followed by DT104b at 17.9% (12 of 67 isolates) ( Table 2 ). DT104b occurred 50% more frequently in human clinical strains (8 of the 12 strains of phage type DT104b) than in veterinary isolates (4 of the 12 strains of phage type DT104b) and was absent in strains obtained from food sources. Five other phage types were observed (Table 2) .
Upon visualization of the PFGE results for the 56 strains of S. enterica serotype Typhimurium DT104 and DT104b digested with XbaI, BlnI, and SpeI, PFGE gels identified 15 individual PFGE banding patterns. The most predominant banding pattern observed was designated X1aB1aS1a and was observed in 21 isolates of both phage type DT104 and phage type DT104b from all three sources (Table 3 ). The remaining PFGE banding patterns are summarized in Table 3 .
This study has utilized a combination of phenotypic and genotypic typing methods to observe a relationship among strains of S. enterica serotype Typhimurium isolated from human, food, and animal sources in the midwest region of Ireland. The data reported here demonstrate a high level of drug resistance (98.5% [66 of 67 strains]) associated with S. enterica serotype Typhimurium, a result which correlates with those of studies performed in the European Union (6, 14, 30, 22) . Multidrug resistance was observed in 88% (59 of 67) of S. enterica serotype Typhimurium strains, and the resistance profile for 77.6% (52 of 67) of these strains was ACSSuT. In the 1990s, a new S. enterica serotype Typhimurium phage type DT104 expressing this pentaresistance profile emerged in many countries and has been reported in Ireland (15), the United Kingdom (30, 31) , the United States (10, 23), Canada (21), and Denmark (2, 3). The ACSSuT resistance profile has been shown to be chromosomally integrated (26) , suggesting that the withdrawal of antimicrobial agents would not have any effect on the current epidemic of DT104. Portentously, strains of S. enterica serotype Typhimurium expressing resistance to trimethoprim-sulfamethoxazole in addition to this pentaresistance profile are highlighted in this study. Furthermore, all trimethoprim-sulfamethoxazole resistance was associated with additional resistance to one or more of the five antimicrobials with the pentaresistance profile ACSSuT. Resistance such as this may be associated with the use of trimethoprim to combat bovine infections, as was observed by Threlfall et al. in the United Kingdom during the late 1970s (28) and more recently in the early 1990s (29) .
All strains of S. enterica serotype Typhimurium were susceptible to the second-generation fluoroquinolones; however, two bovine isolates expressed resistance to the first-generation quinolone nalidixic acid. The emergence of nalidixic acid-resistant Salmonella is a cause for concern, as fluoroquinolone and reduced fluoroquinolone resistance have been associated with nalidixic acid resistance (11, 20) . During this study, six different S. enterica serotype Typhimurium phage types were observed. Accounting for 75% of all S. enterica serotype Typhimurium strains, DT104 was the most prevalent phage type observed in both cattle and human patients. Similar observations have been reported in other studies in the United Kingdom (27, 31) , the United States (10, 23) , and Canada (21) . DT104 was first observed in cattle in Ireland in 1995, and incidences of this phage type have continued to escalate from 2 in 1995 to 85 in 1998. In comparison, the first case of DT104b was observed in cattle in 1996 and incidences have since remained relatively low (8) .
Although PFGE has been used in international studies of S. 
a A, ampicillin; Amc, coamoxiclavulanic acid; C, chloramphenicol; Na, nalidixic acid; S, streptomycin; Su, sulfonamides; T, tetracycline; X, trimethoprimsulfamethoxazole; I, intermediate resistance. The 52 strains with the ACSSuT pentaresistance profile are shown in the first five rows. This study suggests that at present Ireland is suffering from an epidemic of S. enterica serotype Typhimurium DT104. It is therefore imperative that food handlers, veterinarians, and people working with animals recognize the possibility of crosscontamination of this microorganism. Furthermore, this study identified the need for future surveillance and monitoring of the potential epidemic strains of S. enterica serotype Typhimurium DT104b expressing multiple resistances.
